in the same direction with regard to proprietary trading in the following matters: (1) General Provisions shall be in accordance with Chapter 1; (2) Additional Rules for Proprietary Trading of
the same direction with regard to proprietary trading in the following matters: (1) General Provisions shall be in accordance with Chapter 1; (2) Additional Rules for Proprietary Trading of Securities
the same direction with regard to proprietary trading in the following matters: (1) General Provisions shall be in accordance with Chapter 1; (2) Additional Rules for Proprietary Trading of Securities
contain certain provisions in relation to restriction of rights and liberty of persons which Section 29, in conjunction with Section 33, Section 34, Section 41, Section 43, Section 44 and Section 64 of the
paragraph of Section 24 of the Derivatives Act B.E. 2546 (2003) which contain certain provisions in relation to restriction of rights and liberty of persons which Section 29, in conjunction with Section 33
certain provisions in relation to the restriction of rights and liberties of persons which Section 29 in conjunction with Section 33, Section 34, Section 36, Section 41, Section 43, and Section 45 of the
certain provisions in relation to the restriction of rights and liberties of persons which Section 29 in conjunction with Section 33, Section 34, Section 36, Section 41, Section 43, and Section 45 of the
certain provisions in relation to the restriction of rights and liberties of persons which Section 29 in conjunction with Section 33, Section 34, Section 36, Section 41, Section 43, and Section 45 of the
. Investment in raw material extraction plant and world-class research laboratory 100 100 100 - 2018-2019 2. Development of the Company’s new brand 200 200 200 - 2018-2020 บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน
percent Purposes of use of proceeds disclosed in the registration statement for offer for sale of securities and draft prospectus 1. Investment in raw material extraction plant and world-class research